Attitudes and perceptions towards HPV vaccination among young women in Saudi Arabia

被引:48
作者
Hussain, Aneela N. [1 ]
Alkhenizan, Abdullah [1 ]
McWalter, Patricia [1 ]
Qazi, Nusrat [1 ]
Alshmassi, Amal [1 ]
Farooqi, Samina [1 ]
Abdulkarim, Ahmed [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Family Med & Polyclin, Riyadh, Saudi Arabia
关键词
Adolescents; attitude; human papillomavirus vaccination; perception; Saudi Arabia;
D O I
10.4103/2230-8229.189107
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Rising incidence of human papillomavirus (HPV) infection and cervical cancer can be reduced by effective vaccination. Saudi Food and Drug Administration approved prophylactic HPV vaccine in 2010 for females of 11-26 years. Objectives: To determine the awareness of HPV infection, its health sequel and the attitude and barriers to the acceptance of HPV vaccine by young women in Saudi Arabia. Dynamics influencing the decision of patients and parents regarding vaccination were assessed to foster effective and strategically focused interventions. Materials and Methods: All patients of Family Medicine department, King Faisal Specialist Hospital and Research Center, Riyadh were invited to participate in this study from January 2012 to June 2014. A culturally sensitive and specially designed questionnaire was administered using an interview-based model to assess the knowledge, perception, and associated sociodemographic factors of HPV. Results: A total of 325 patients participated as per the inclusion criteria: 87.4% were Saudis, 53.5% had university or higher education and 65.2% were adolescents (age 11-19 years). The questionnaire was answered by participants (50.8%) or guardians (49.2%). About 34.5% of the population was aware of HPV infection, and 27.4% were aware of its relation with cervical cancer. However, awareness of the HPV vaccine, perception of its prevention of cervical cancer and other HPV-related disease was relatively low (32.3%), Saudis (29.9%) versus non-Saudis (48.8%) (P = 0.016). More guardians (41.2%) were aware of the HPV vaccine and its impact than participants (27.9%) (P = 0.01). Higher educational background (43.1%) increased the knowledge of HPV compared to less than high school education (24.5%) (odds ratio: 2.33; 95% confidence interval: 1.44-3.76). Nearly 64.3% of participants agreed, and 35.7% refused to receive the HPV vaccine. Conclusion: Knowledge and perception of HPV infection as an sexually transmitted infections and its vaccine was significantly low in this cohort of patients. Higher age and educational levels directly correlated with increased knowledge of HPV infection and its complications. It is recommended that awareness should be raised, and access to HPV vaccination increased to help reduce the health care burden of HPV sequelae in the Kingdom.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 28 条
  • [11] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [12] Attitudes to HPV vaccination among mothers in the British Jewish community: Reasons for accepting or declining the vaccine
    Gordon, Daniel
    Waller, Jo
    Marlow, Laura A. V.
    [J]. VACCINE, 2011, 29 (43) : 7350 - 7356
  • [13] Hahn Robert, 2007, MMWR Recomm Rep, V56, P1
  • [14] Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study
    Jaspers, L.
    Budiningsih, S.
    Wolterbeek, R.
    Henderson, F. C.
    Peters, A. A. W.
    [J]. VACCINE, 2011, 29 (44) : 7785 - 7793
  • [15] Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]
  • [16] Annual Report to the Nation on the Status of Cancer, 19752009, Featuring the Burden and Trends in Human Papillomavirus (HPV)Associated Cancers and HPV Vaccination Coverage Levels
    Jemal, Ahmedin
    Simard, Edgar P.
    Dorell, Christina
    Noone, Anne-Michelle
    Markowitz, Lauri E.
    Kohler, Betsy
    Eheman, Christie
    Saraiya, Mona
    Bandi, Priti
    Saslow, Debbie
    Cronin, Kathleen A.
    Watson, Meg
    Schiffman, Mark
    Henley, S. Jane
    Schymura, Maria J.
    Anderson, Robert N.
    Yankey, David
    Edwards, Brenda K.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (03): : 175 - 201
  • [17] A controlled trial of a human papillomavirus type 16 vaccine
    Koutsky, LA
    Ault, KA
    Wheeler, CM
    Brown, DR
    Barr, E
    Alvarez, FB
    Chiacchierini, LM
    Jansen, KU
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) : 1645 - 1651
  • [18] Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
    Kreimer, Aimee R.
    Cecilia Rodriguez, Ana
    Hildesheim, Allan
    Herrero, Rolando
    Porras, Carolina
    Schiffman, Mark
    Gonzalez, Paula
    Solomon, Diane
    Jimenez, Silvia
    Schiller, John T.
    Lowy, Douglas R.
    Quint, Wim
    Sherman, Mark E.
    Schussler, John
    Wacholder, Sholom
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (19): : 1444 - 1451
  • [19] Vaccines for cervical cancer - Editorial review
    Lowndes, CM
    [J]. EPIDEMIOLOGY AND INFECTION, 2006, 134 (01) : 1 - 12
  • [20] Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India
    Madhivanan, Purnima
    Krupp, Karl
    Yashodha, M. N.
    Marlow, Laura
    Klausner, Jeffrey D.
    Reingold, Arthur L.
    [J]. VACCINE, 2009, 27 (38) : 5203 - 5208